1. Home
  2. FMBH vs DBVT Comparison

FMBH vs DBVT Comparison

Compare FMBH & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

HOLD

Current Price

$42.71

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.02

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMBH
DBVT
Founded
1865
2002
Country
United States
France
Employees
N/A
90
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
FMBH
DBVT
Price
$42.71
$20.02
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$43.40
$32.04
AVG Volume (30 Days)
65.2K
197.0K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
2.33%
N/A
EPS Growth
16.06
10.26
EPS
1.06
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
$9.30
$35.04
Revenue Next Year
$6.66
$2,360.78
P/E Ratio
$40.40
N/A
Revenue Growth
N/A
35.77
52 Week Low
$33.67
$7.53
52 Week High
$44.85
$26.19

Technical Indicators

Market Signals
Indicator
FMBH
DBVT
Relative Strength Index (RSI) 48.14 47.84
Support Level $42.36 $18.89
Resistance Level $42.85 $21.61
Average True Range (ATR) 0.94 0.81
MACD -0.11 0.00
Stochastic Oscillator 48.18 44.92

Price Performance

Historical Comparison
FMBH
DBVT

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: